Can You Give a Child Both Clindamycin and Keflex for a Severe Infection?
No, you should not routinely give both clindamycin and cephalexin (Keflex) together for a severe infection in a child. These antibiotics are typically used as alternatives to each other, not in combination, and there is no evidence supporting their combined use for most pediatric infections.
Why These Antibiotics Are Not Combined
Overlapping Coverage Without Synergy
Both clindamycin and cephalexin target gram-positive organisms, particularly Staphylococcus aureus and Streptococcus species. Using them together provides redundant coverage rather than complementary activity 1, 2. The guidelines consistently list these as alternative options for the same pathogens, not as combination therapy.
Specific Clinical Scenarios
For Methicillin-Susceptible S. aureus (MSSA):
- Preferred oral therapy: Cephalexin 75-100 mg/kg/day in 3-4 doses
- Alternative: Clindamycin 30-40 mg/kg/day in 3-4 doses
- These are listed as alternatives, not to be used together 1, 2
For Methicillin-Resistant S. aureus (MRSA):
- Preferred: Clindamycin alone (if susceptible) 30-40 mg/kg/day orally 2
- Cephalexin has no activity against MRSA and should not be used 3
For Streptococcal infections:
- Preferred: Amoxicillin or penicillin
- Alternatives include either cephalexin OR clindamycin, not both 1, 2
When Combination Therapy IS Indicated
The only scenario where adding clindamycin to a beta-lactam makes sense is:
For suspected S. aureus with severe/necrotizing infection:
- Vancomycin or clindamycin should be added to beta-lactam therapy if clinical features suggest staphylococcal infection 1
- However, this would typically be vancomycin PLUS a third-generation cephalosporin (ceftriaxone/cefotaxime), not cephalexin
- The rationale is adding anti-toxin effects of clindamycin, not antimicrobial synergy 4
The Right Approach: Choose One Based on the Pathogen
If MSSA is confirmed or suspected:
Use cephalexin alone: 75-100 mg/kg/day divided every 6-8 hours (maximum 4 g/day) 2, 5
If MRSA is confirmed or suspected:
Use clindamycin alone: 30-40 mg/kg/day divided every 6-8 hours (maximum 1.8 g/day) 2, 3
If the pathogen is unknown in a severe infection:
- Hospitalized patients: Use IV therapy with ceftriaxone or cefotaxime ± vancomycin/clindamycin if MRSA suspected 1
- Outpatient with abscess: Incision and drainage is more important than antibiotic choice; clindamycin covers both MSSA and community-acquired MRSA 3, 6
Important Safety Considerations
Cross-allergenicity warning: Cephalexin carries a warning about potential cross-reactivity in penicillin-allergic patients (up to 10% risk) 7. If a child has a penicillin allergy, clindamycin would be the safer choice.
C. difficile risk: Both antibiotics can cause Clostridium difficile-associated diarrhea, and using them together would theoretically increase this risk without clinical benefit 7.
Clinical Evidence
A randomized controlled trial directly compared cephalexin versus clindamycin for uncomplicated pediatric skin infections (69% caused by MRSA). There was no significant difference in outcomes: 94% improved with cephalexin vs. 97% with clindamycin by 48-72 hours 6. This demonstrates that even when MRSA is present, appropriate wound care may be more important than antibiotic choice for uncomplicated infections—and certainly doesn't support using both antibiotics together.
Bottom line: Select one antibiotic based on the suspected pathogen and local resistance patterns. If the infection is severe enough to consider combination therapy, the child likely needs hospitalization and IV antibiotics, not oral cephalexin plus clindamycin.